Relay Therapeutics, Inc. RLAY Other comprehensive income (loss)
Other comprehensive income (loss) at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossNetOfTax.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s other comprehensive income (loss).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s other comprehensive income (loss)?
- Relay Therapeutics, Inc. (RLAY) reported other comprehensive income (loss) of -$172K in Q1 2026.
- How has Relay Therapeutics, Inc.'s other comprehensive income (loss) changed year-over-year?
- Relay Therapeutics, Inc.'s other comprehensive income (loss) decreased by 116.7% year-over-year, from $1.03M to -$172K.
- What is the long-term trend for Relay Therapeutics, Inc.'s other comprehensive income (loss)?
- Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s other comprehensive income (loss) has grown at a 10.6% compound annual growth rate (CAGR), from -$1.15M to $1.72M.
- What does other comprehensive income (loss) mean?
- This metric encompasses all changes in equity during a period that result from transactions and other events, excluding those from transactions with owners in their capacity as owners. It includes items such as unrealized gains or losses on available-for-sale securities and foreign currency translation adjustments. It serves as a broader measure of financial performance beyond the traditional net income statement.